Clinical Application of Next-Generation Sequencing in Patients With Breast Cancer: Real-World Data-Reference-Cited by-同舟云学术

Clinical Application of Next-Generation Sequencing in Patients With Breast Cancer: Real-World Data

Published:2022 Issue:5 Volume:25 Page:366
ISSN:1738-6756
Container-title:Journal of Breast Cancer
language:en
Short-container-title:J Breast Cancer

Author:

Suh Koung Jin¹^ORCID,Kim Se Hyun¹^ORCID,Kim Yu Jung¹^ORCID,Shin Heechul²^ORCID,Kang Eunyoung²^ORCID,Kim Eun-Kyu²^ORCID,Lee Sejoon³⁴^ORCID,Woo Ji Won⁴^ORCID,Na Hee Young⁴^ORCID,Ahn Soomin⁴^ORCID,Jang Bum-Sup⁵^ORCID,Kim In Ah⁵^ORCID,Park So Yeon⁴^ORCID,Kim Jee Hyun¹³^ORCID

Affiliation:

1. Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

2. Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

3. Precision Medicine Center, Seoul National University Bundang Hospital, Seongnam, Korea.

4. Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

5. Department of Radiation Oncology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

Publisher

Korean Breast Cancer Society

Subject

Cancer Research,Oncology

Link

https://ejbc.kr/pdf/10.4048/jbc.2022.25.e30

Reference28 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. National Cancer Information Center. National Cancer Information Center’s homepage. 2021. Accessed December 12th, 2021. https://www.cancer.go.kr

3. Molecular portraits of human breast tumours

4. FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer

5. Center for Drug Evaluation and Research. FDA approves olaparib for germline BRCA-mutated metastatic breast cancer. 2018. Accessed July 18th, 2021. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-olaparib-germline-brca-mutated-metastatic-breast-cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-Generation Sequencing in Breast Cancer Patients: Real-World Data for Precision Medicine;Cancer Research and Treatment;2024-01-15

2. Tackling the implementation gap for the uptake of NGS and advanced molecular diagnostics into healthcare systems;Heliyon;2024-01

3. Genomics in Clinical trials for Breast Cancer;Briefings in Functional Genomics;2023-12-23

4. Ubiquitin-conjugating enzyme 2C (UBE2C) plays as a cancer diagnostic and prognostic marker: A Bioinformatics pan-cancer analysis;2023-09-20

5. Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement;eClinicalMedicine;2023-06